Key result
Visceral adipose tissue volume (6.9 L vs 3.4 L) and VAT/SAT volume ratio were significantly higher in subjects with diabetes compared to healthy controls, independent of cardiovascular risk factors.
Why the study?
Are MRI-derived visceral and subcutaneous adipose tissue volumes and their ratio associated with impaired glucose metabolism in subjects without cardiovascular disease?
Case-Control (n=384)
Single-blind
No
Are MRI-derived visceral and subcutaneous adipose tissue volumes and their ratio associated with impaired glucose metabolism in subjects without cardiovascular disease?
Absolute Event Rate: 6.9% vs 3.4%
p-value: p=<0.02
MRI-quantified visceral adipose tissue volume and VAT/SAT ratio are significantly elevated in subjects with impaired glucose metabolism independent of cardiovascular risk factors, serving as reproducible biomarkers of cardiometabolic risk.
VAT volume and ratio support cardiometabolic risk links in prediabetes; hypothesis-generating for MRI biomarkers, needs prospective validation.
Objective: To study the relationship of area- and volumetric-based visceral and subcutaneous adipose tissue (VAT and SAT) by MRI and their ratio in subjects with impaired glucose metabolism from the general population. Methods: Subjects from a population-based cohort with established prediabetes, diabetes and healthy controls without prior cardiovascular diseases underwent 3 T MRI. VAT and SAT were assessed as total volume and area on a single slice, and their ratio (VAT/SAT) was calculated. Clinical covariates and cardiovascular risk factors, such as hypertension and glycemic state were assessed in standardized fashion. Univariate and adjusted analyses were conducted. Results: Among 384 subjects (age: 56.2 ± 9.2 years, 58.1% male) with complete MRI data available, volumetric and single-slice VAT, SAT and VAT/SAT ratio were strongly correlated (all >r = 0.89). Similarly, VAT/SATvolume ratio was strongly correlated with VATvolume but not with SAT (r = 0.72 and r = −0.21, respectively). Significant higher levels of VAT, SAT and VAT/SAT ratio were found in subjects with impaired glucose metabolism (all p ≤ 0.01). After adjustment for potential cardiovascular confounders, VATvolume and VAT/SATvolume ratio remained significantly higher in subjects with impaired glucose metabolism (VATvolume = 6.9 ± 2.5 l and 3.4 ± 2.3 l; VAT/SATvolume ratio = 0.82 ± 0.34 l and 0.49 ± 0.29 l in patients with diabetes and controls, respectively, all p < 0.02), whereas the association for SATvolume attenuated. Additionally, there was a decreasing effect of glycemic status on VAT/SATvolume ratio with increasing body mass index and waist circumference (p < 0.05). Conclusions: VATvolume and VAT/SATvolume ratio are associated with impaired glucose metabolism, independent of cardiovascular risk factors or MRI-based quantification technique, with a decreasing effect of VAT/SATvolume ratio in obese subjects. Advances in knowledge: Quantification of VATvolume and VAT/SATvolume ratio by MRI represents a reproducable biomarker associated with cardiometabolic risk factors in subjects with impaired glucose metabolism, while the association of VAT/SATvolume ratio with glycemic state is attenuated in obese subjects.
No takes yet. Share an insight, caveat, or question.
Storz et al. (2018) conducted a case-control in Prediabetes and Diabetes (n=384). Impaired glucose metabolism (prediabetes and diabetes) vs. Healthy controls was evaluated on Visceral adipose tissue (VAT) volume (p=<0.02). Visceral adipose tissue volume (6.9 L vs 3.4 L) and VAT/SAT volume ratio were significantly higher in subjects with diabetes compared to healthy controls, independent of cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: